title: Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients.
abstract: OBJECTIVE
  Interleukin 1 (IL-1) and IL-10 are critically involved in tumorigenesis. We investigated polymorphisms of IL-1 and IL-10 genes in patients with ovarian cancer (OC).
  
  
  METHODS
  In a prospective, case-control study 147 patients with OC and 129 patients without history of any malignancy (CG) were genotyped for IL-1 gene (IL-1alpha -889 T/C and IL-1beta -511 C/T) and IL-10 gene (IL-10 -1082 G/A, -819 C/T and -592 C/A) using pyrosequencing.
  
  
  RESULTS
  IL-10 polymorphisms in -819 and -592 positions correlated with the postoperative residual tumor mass (p=0.036 and p=0.035, respectively). The chance of achieving optimal tumor debulking was 1.49 times greater for patients with the C/C genotype at -819 and -512 positions than for patients with other genotypes. There were no significant associations between allelic frequencies for IL-1alpha and IL-1beta in OC. IL-10 -819 CC and -592 CC genotypes were associated in univariate analysis with a better disease-free and overall survival.
  
  
  CONCLUSIONS
  IL-10 promoter polymorphism may be related with the ability to achieve optimal tumor debulking. Polymorphism in IL-10 gene seems to influence the overall and disease-free survival rate. Subsequent multi-institutional studies with high number of patients are warranted to confirm these results.
authors.affiliation: Department of Gynecology and Obstetrics, Charité/Campus Virchow-Klinikum, Charité Medical University of Berlin, Germany. ioana@braicu.de
authors.forename: Elena
authors.initials: E
authors.lastname: Ioana Braicu
authors.forename: Alexander
authors.initials: A
authors.lastname: Mustea
authors.forename: Mohammad R
authors.initials: MR
authors.lastname: Toliat
authors.forename: Cristina
authors.initials: C
authors.lastname: Pirvulescu
authors.forename: Dominique
authors.initials: D
authors.lastname: Könsgen
authors.forename: Pengming
authors.initials: P
authors.lastname: Sun
authors.forename: Peter
authors.initials: P
authors.lastname: Nürnberg
authors.forename: Werner
authors.initials: W
authors.lastname: Lichtenegger
authors.forename: Jalid
authors.initials: J
authors.lastname: Sehouli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics*; D053582:Interleukin-1alpha / Q000235:genetics*; D053583:Interleukin-1beta / Q000235:genetics*; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D020641:Polymorphism, Single Nucleotide
chemical_list: D053582:Interleukin-1alpha; D053583:Interleukin-1beta; D016753:Interleukin-10